- Managed Entry Agreements for
- Managed Entry Agreements for
Oncology Drugs - Input Time : 2019-11-15
- [Download file]
- [Reporter’s View] Doctors agree Korea’s reimb is too slow
- Reporter's view | Eo, Yun-Ho
-
- 'Viatris will lead market with innovation and leadership'
- Bill Schuster, Representative Director & Country Manager of Viatris Korea
-
- "Livtencity offers new CMV trt for transplant patients"
- Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
-
- ‘SGLT2i+TZD promising for diabetics with fatty liver risk’
- Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
MOST READ
